SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 460.80
arrow_upward
+0.39%(+1.80) 1D
Oct 27, 3:38:37 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 475.00
High
SEKÂ 478.00
Low
SEKÂ 451.20
Mkt. cap
164.80B
Avg. vol.
292.33K
Volume
320.79K
P/E ratio
123.07
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 475.00
High
SEKÂ 478.00
Low
SEKÂ 451.20
Mkt. cap
164.80B
Avg. vol.
292.33K
Volume
320.79K
P/E ratio
123.07
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
Seeking Alpha
·
39 minutes ago
Swedish Orphan Biovitrum AB (publ) 2026 Q3 - Results - Earnings Call Presentation (OTCMKTS:SWOBY) 2026-10-27
TradingView
·
55 minutes ago
SOBI Q3 2026 Earnings Call Is Live
Investing.com
·
6 hours ago
Why is Swedish Orphan Biovitrum stock rallying today?
Investing.com
·
6 hours ago
Sobi raises revenue outlook as third quarter beats estimates; shares gain
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)